News

on
Dr. Wally Smith  a professor of sickle cell disease at Virginia Commonwealth University in Richmond
|
Research Feature
As the country struggles with the devastating opioid crisis, researchers say it could have dire consequences for one population with few pain-relieving alternatives: people living with sickle cell disease. The increasingly tight restrictions on opioid access, they say, is stirring fears that patients will face greater scrutiny than they already do...
Sickle cell patient.
|
Research Feature
Jennifer Nsenkyire (pronounced ‘century’) has suffered from sickle cell disease for as long as she can remember. As a teenager growing up in her native Ghana, she endured the excruciating pain caused by the condition sometimes for days at a time. At least once a month she had to be hospitalized, and blood transfusions came at a steady, troubling pa...
|
News Release
A sickle cell anemia study has found that the drug hydroxyurea is as effective as blood transfusions in children to reduce blood flow velocities in the brain, which is a key risk factor for stroke. The findings appear in The Lancet and were presented at the annual meeting of the American Society of Hematology. Some children living with sickle cell...
3d illustration of sickle cell anemia
|
News Release
WHAT : An analysis by National Institutes of Health researchers has shown that people with sickle cell anemia who took the drug hydroxyurea at the recommended dose had higher survival rates than those who took less than the recommended dose. The findings appear in the journal PLOS ONE. Researchers at the National Heart, Lung and Blood Institute (NH...
blood cells blue
|
Research Feature
DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Announcement of Requirements and Registration for “Novel, Innovative Tools to Increase Public Awareness and Knowledge of Sickle Cell Disease Undergraduate Challenge” Authority:15 U.S.C. 3719 Agency: Department of Health and Human Services (HHS), National Institutes of Health, Nat...